Marstacimab for hemophilia b

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Nov 2021: Trial started, NCT05145127
  2. 6 Dec 2021: Trial registered, NCT05145127

The trials

NCT05145127: Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

State
Under way
Phase
Phase 3
People
245 planned
Started
17 Nov 2021
Primary completion
31 Jul 2030
Arms
PF-06741086
Results
None posted
  1. 17 Nov 2021: Trial started
  2. 6 Dec 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.